Short Communication, Endocrinol Diabetes Res Vol: 6 Issue: 3
3rd International conference on Diabetes, Hypertension and Metabolic Syndrome, February 24-25, 2020 Tokyo, JapanSerge P. Bottari
Alps University School of Medicine and Hospital, France
Email: Bottari, [email protected]
We are overwhelmed to announce “3rd International Conference on Diabetes, Hypertension & Metabolic Syndrome” which is going to be held during February 24- 25, 2020 at Tokyo, Japan. The Conference will be organized around the theme “Collection of advanced therapies: Prevention of Diabetes & Metabolic syndrome”.
This conference highlights the latest and exciting innovations in Diabetes & its Treatment. Diabetes 2020 Conference invites all renowned scientists, endocrinologists, surgeons, dietitians, radiation therapists, general physicians, primary health care specialists, talented young scientists, pharmaceutical industrial delegates and student communities across the globe to attend International Diabetes congress.
Importance & Scope:
Millions of people are suffering and also trying all kinds of diets, pills, and treatments to clear their mental fog, to boost energy and lose weight. Unfortunately, they will all fail unless they learn how to heal the underlying Diabetes issues.
Number of people suffering from Diabetes disorders continues to rise each year. As reported by the World Health Organization (WHO), on an average 1 out of every 13 people are diagnosed globally with Diabetes each year and also projects that diabetes will be the 7th leading cause of death in 2030. Around 60% of the populations effected with Diabetes diseases are uncaring of the situation.
Diabetes Meet 2020 will feature the latest developments in research, diagnosis and prevention of diabetes, new insulin analogues, new technologies and devices for diabetic prevention, obesity and many more. Not only will this innovative conference enhance your practical and theoretical knowledge but also provides you with the unique opportunity to network with a wide range of professionals in the field of diabetes.
Global Diabetes Prevalence:
The world prevalence of diabetes among adults is 6.4%, affecting 285 million adults in 2010. It will increase to 7.7% and 439 million adults by 2030. Between 2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in developing countries and a 20% increase in developed countries.
Diabetes is one of the fastest growing health challenges of the 21st century, with the number of adults living with diabetes having more than tripled over the past 20 years. In 2000, the global estimate of adults living with diabetes was 151 million. By 2009 it had grown by 88% to 285 million. Today, we calculate that 9.3% of adults aged 20–79 years – a staggering 463 million people – are living with diabetes. A further 1.1 million children and adolescents under the age of 20 live with type 1 diabetes. A decade ago, in 2010, the global projection for diabetes in 2025 was 438 million. With over five years still to go, that prediction has already been surpassed by 25 million will be 578 million adults with diabetes by 2030, and 700 million by 2045.
World 28th International Diabetes and Healthcare ConferenceHelsinki, Finland